Litigation In Brief
This article was originally published in The Gray Sheet
Executive Summary
Diomed patent case proceeds to trial: U.S. District Court for Massachusetts finds that Diomed's patent on endovascular laser treatment for varicose veins is valid and enforceable. In a sealed order, dated Aug. 30, the Massachusetts court grants Diomed's motion for summary judgment, rejecting the patent invalidity claims by AngioDynamics and Vascular Solutions. The ruling relates to Diomed's patent on its EndoVenous Laser Treatment, which it acquired in 2003. The firm brought charges in 2004 against AngioDynamics (VenaCure) and Vascular Solutions (Vari-Lase) seeking injunctive relief and damages for alleged infringement. With the validity issue decided, Diomed is cleared to proceed to trial, expected to commence in 2007. The defendants hold that the decision is not a determination of whether patent infringement has actually occurred...
You may also be interested in...
S&N’s BlueSky Purchase Puts Negative Pressure On Kinetic Concepts
Smith & Nephew's entry into the rapidly growing, $1.2 billion market for negative pressure wound therapy via the purchase of BlueSky Medical likely will intensify competition in the treatment category
S&N’s BlueSky Purchase Puts Negative Pressure On Kinetic Concepts
Smith & Nephew's entry into the rapidly growing, $1.2 billion market for negative pressure wound therapy via the purchase of BlueSky Medical likely will intensify competition in the treatment category
Angiodynamics Looks To Overcome Legal Woes, Regain Momentum
Angiodynamics' plan to sidestep patent infringement concerns relating to its VenaCure laser system for varicose veins could help boost sales growth and lift the cloud over the firm's stock performance after a poor showing in the first quarter